 |
Chairman
 Rick
Randall
Chairman 2010/2011
Rick Randall is the Chief Executive Officer of TranS1, Inc, a company dedicated
to developing and marketing minimally invasive therapies to treat lower back
pain.
Rick served as President and CEO of Innovasive Devices, Inc. from 1994 to 2000,
when the firm was acquired by the Ethicon Division of Johnson & Johnson.
Innovasive Devices was a developer, manufacturer and marketer of arthroscopic
surgical products.
From 1989 to 1996 Rick served as President, Chairman and Director of Target
Therapeutics, Inc., a medical device company serving the interventional
neurosurgery market. Target was acquired by Boston Scientific, Inc in 1997.
Prior to Target, he held various sales and marketing management positions with
Trimedyne, Inc., Baxter Edwards and the USCI Division of C.R. Bard, Inc.
He is also co-founder of Conceptus, Inc. and Cardima, Inc., and is a Director of
AbbeyMoor Medical and Salient Surgical Technologies.
Rick earned a Bachelor of Science degree from State University College at
Buffalo, Buffalo, NY.
 Board of Directors
 Albert "Ace" C. Edwards
SEMDA President
Ace has been involved in the electronics industry for the past thirty-five
years, the past eight in medical devices. Currently he provides manufacturing,
fabrication & design/engineering services to manufacturers. Prior to this he was
the Director of Sales, Marketing, and Business Development at Sector Electronics
and Sector Medical Corp. Sector Medical was a start-up medical device company
that developed and marketed a screening device for Obstructive Sleep Apnea.
During this time he also started a Home Health Agency providing in-home care for
seniors.
Prior to working with Sector he spent sixteen years working for a fortune 200
company in electronic interconnection systems. He worked up through the sales
ranks to the position of National Sales Manager and the Director of Global
Marketing.
Ace holds a bachelors degree in Industrial Management from the Georgia Institute
of Technology and his master’s degree in Business and Entrepreneurship from Wake
Forest Babcock School of Management.
 David
B. Hartnett
SEMDA Vice President (President Elect 2011/2012)
David Hartnett is Vice President, Economic Development for the Metro Atlanta
Chamber of Commerce, specializing in high tech and bioscience. He has more than
19 years of senior management, Medical Device/Pharmaceutical, and Telemedicine -
IT healthcare experience with early stage to publicly traded companies.
David’s diverse experience has contributed to the success of six premier medical
device companies receiving international recognition. He has served as a lead in
the management, development and commercialization of over 14 medical devices,
ranging in classification.
Prior experience includes Managing Director of Medical Device Marketing® and
President and Chief Executive Officer of UnitedPharma®. He has also held
positions as President, CEO of SteriFx® Corporation, Given Imaging, Inc. ERBE
Electrosurgery, Karl Storz Lithotripsy, Genzyme® (formerly Deknatel), STERIS®
(formerly AMSCO®) and the XEROX® Corporation.
David holds a B.Sc. in Speech Communication, from San Diego State University
with a master’s equivalent in Marketing through Post Graduate executive
management studies.
 Robert Natowitz
SEMDA Treasurer
Robert Natowitz is the President of Ideal Search Services LLC. His focus is
talent acquisition in the medical device field nationwide. He specializes in
engineering recruitment, to include product development, R&D, design assurance
and quality. Prior to relocating to Atlanta, he spent ten years as partner at
DeMatteo Associates, a specialty search firm in Albany, NY.
Rob is a member of the American-Israel Chamber of Commerce. He is a volunteer at
the Outreach and Advocacy Center which serves the homeless and near-homeless in
downtown Atlanta. He received a BA in English from the State University of New
York at Potsdam.
 Charlie
Harrison
SEMDA Secretary (President Elect 2012/2013)
Charlie Harrison, President and CFO of Wynden Pharmaceuticals, Inc., brings 35
years of marketing and operating experience in driving new product and business
commercialization in pharmaceutical, device and biotech markets.
Prior to founding Wynden, Charlie was founder and President of Critical
Strategies, LLC, providing business development and strategic advisory support
to life science companies. Prior to Critical Strategies, Charlie served in a
series of senior management roles with Serologicals, Creative Product Resource,
Unimed, SmithKline (now GSK) and Organon (now Schering).
Charlie serves on the Boards of the American-Israel Chamber of Commerce,
Southeast Region and Medical Compression Systems Ltd., a public Israel-based
medical device company. Charlie received his BS in Mathematics from Pennsylvania
State University and his MBA from the University of Massachusetts.
 John G. Edwards
SEMDA Past-President
John Edwards is founder and CEO of Apeliotus Technologies, a medical device
company that develops and commercializes products based on innovations from
universities in the Southeast.
John has been involved in technology commercialization for more than 25 years at
four successful university spin-off companies and a major university research
lab.
John holds SB and SM degrees in physics from MIT and an MBA from the University
of Chicago.
 Mark
Fishman
SEMDA Tax & Financial Advisor
Mark is a CPA with more than 14 year of experience in public accounting. He joined Cain & David in 2005 as a Partner. Mark’s areas of practice include medical devices, manufacturing, technology, telecommunications, distribution, entertainers and athletes, and services companies. He also is the partner in charge of the firm’s state and local tax practice (SALT) with a specialty in multi state tax planning, tax credits, nexus requirements, sales tax and ad valorem tax issues. Mark holds a BS in Accounting from Longwood College and an MS in Taxation from American University. He is currently an adjunct professor at Oglethorpe University.
 Scott Allen
Scott L. Allen is a senior associate in the firm’s Medical Device and Corporate and Securities Practices. His practice focuses primarily on representing public and private companies in general corporate matters, mergers and acquisitions, venture capital and public securities offerings and reporting requirements.
Mr. Allen’s practice covers a wide variety of industries, with extensive experience representing clients in the medical device, information technology and telecommunications industries. Mr. Allen routinely advises a range of clients, including start-up, middle market and large cap companies, in complex mergers and acquisitions, venture capital, and corporate finance issues, involving both domestic and cross-border transactions.
Mr. Allen has been recognized as a leading young attorney in the corporate practice area by being selected as Georgia Super Lawyers Rising Star, as published by Law & Politics and Atlanta magazines on numerous occasions. Mr. Allen is also a frequent speaker on corporate law, M&A and private equity topics for continued legal education programs, trade association events and related conferences.
Tom
Brooks
Tom Brooks is a serial entrepreneur with over 22 years of medical device and
healthcare experience. He was one of the founding members of a new division of
Ethicon, Endo-Surgery, a Johnson & Johnson company. He led Boston Scientific’s
Business Development team into four new markets from 1986 to 1994. He was one of
the original members of the senior management team for Novoste Corporation in
Atlanta from 1995 until1999 when he left to start a healthcare IT company. In
April 2000, he sold the healthcare IT company he founded with a physician. In
2001, he joined Conor Medsystems, a drug delivery company. As President, he
helped raise multiple rounds of funding before leaving to start Healthcare
Capital Partners, a Venture Capital fund, in August 2003.
Tom is Managing Partner for HealthCare Capital Partners, an Atlanta-based
Venture Capital firm specializing in making seed and early-stage investments in
healthcare companies, including medical technology, medical devices and
diagnostics. Typical investments are: (1) between $150,000 to $1.5 million
initially, reaching a total investment of $1 to $4 million in any one company;
(2) syndicated with other leading venture capital firms throughout the country;
and (3) located in the Southeastern U.S.
 Robert
L. Crutchfield
Mr. Crutchfield joined HMC in September 2008 and has more than 20 years of
entrepreneurial and corporate experience in the healthcare industry, working
with both startup, as well as large, international corporations.
Prior to joining Harbert Venture Partners, Mr. Crutchfield served as Senior Vice
President/General Manager of the Pharmacy Services Division at US Oncology, a
privately held, vertically integrated cancer care provider network with cancer
clinics in more than 440 sites of service and a physician network consisting of
over 1000 medical oncologists and radiation oncologists. His division was
responsible for approximately $2 billion of annual revenue and under his
leadership the division’s EBITDA grew to over $80 million.
Mr. Crutchfield was also a Senior Executive at CardinalHealth, where he served
as Vice President of New Ventures. While there, he built and launched a new
surgical products business unit, with revenues of over $75M and EBITDA of $20M
through licensing of new technologies, acquisitions and creating a new North
American sales channel.
In 1995, Mr. Crutchfield founded Surgical Innovations and Services, Inc. (SIS),
a surgical laser management company. Under his leadership, SIS became a leader
in the emerging outsource management sector, with over 300 hospitals and surgery
centers under contract with SIS for management oversight and delivery of their
surgical laser programs. In 2000, SIS merged with Surgical Laser Technologies,
Inc. (SLTI) a publicly traded surgical laser-manufacturing firm. Mr. Crutchfield
continued as President of SIS and served as VP of Sales, Marketing and Business
Development for SLTI until he exited the company following its acquisition by
publicly-traded Photomedex, Inc.,
Mr. Crutchfield has launched five successful new business ventures during his
private and corporate career and has lead four merger and acquisition
transactions. Mr. Crutchfield is a graduate of the University of Georgia and
holds Bachelor of Science degrees in Political Science and Chemistry.
In addition to his responsibilities at Harbert, he is serving on the Governor’s
Science and Technology Roadmap Steering Committee and Chairs the
Commercialization Sub-Committee. He also is a member of the Alabama Obesity
Institute Formation Steering Committee. He is an active member of the Birmingham
Kiwanis Club, a member of the Board of Directors for the Birmingham Venture Club
and Atlanta Venture Forum. He is married to Connie and they have three
college-aged children.
 Paul Gianneschi
Paul Gianneschi is the Managing Principal and Founder of Hatch Medical, L.L.C.,
a privately held medical device incubator and technology brokerage firm focused
on assisting physician inventors, entrepreneurs and early-stage companies with
minimally invasive medical device technologies.
Paul has spent the past 18 years as an executive in the healthcare industry.
Prior to founding Hatch Medical in 2000, Paul served over seven years in a
series of senior level marketing and sales management positions with medical
device industry leader, C. R. Bard, Inc.'s Peripheral Vascular Division. Prior
to joining Bard, Paul worked in similar capacities with Bausch & Lomb and NDC
Health / McKesson.
Paul earned a Bachelor of Science degree from the University of Florida and an
M.B.A. in International Management from Mercer University, where he currently
serves on the board of their business school.
 Rick
Haury
Mr. Haury is a senior executive with CrossLink Life Sciences, LLC, an
Atlanta-based holding company that is engaged through its affiliates in the
distribution and sale of medical devices and is presently launching a venture
arm that will be providing financing to early and mid-stage device companies.
Mr. Haury also serves as the CEO of WebOps Logistics, LLC, which provides a
web-based application that combines service and supply chain processes with
mobile computing and connectivity for companies in the medical device sector.
Prior to joining CrossLink and WebOps, Mr. Haury was an attorney and senior
partner with Morris, Manning & Martin, LLP for 21 years in the corporate,
healthcare, securities and medical device practice groups. Mr. Haury continues
to counsel medical device companies on these matters through his law firm, Haury
Law Group, LLC. Mr. Haury is a co-founder and former president of the
Southeastern Medical Device Association (SEMDA) and is recognized among the
leaders in his field in the Atlanta Business Chronicle’s Who’s Who in
Healthcare. Mr. Haury holds a B.B.A. from Emory University a J.D. from
Vanderbilt University and an M.B.A. from The Owen Graduate School of Management.
 Lynn
Hood
Lynn Hood, President of Hood Marketing Solutions, has more than 25 years of
experience working with agencies and corporations in marketing and
communications. For two decades her agency, Hood Marketing Solutions, has built
a track record of helping companies strategically position themselves in the
marketplace and increase sales through innovative, cost-effective marketing
techniques. The agency specializes in high tech, bioscience and
business-to-business marketing.
Lynn is active in a number of organizations that support Atlanta’s growth. She
is a founding member of SEMDA and Chairman of the Branding Subcommittee for the
Metro Atlanta Chamber of Commerce’s Technology Marketing Initiative. Lynn is
actively involved with Georgia Bio and is on the Advisory Board of its Emerging
Leaders Network. She also serves as marketing chair for the MIT Enterprise Forum
of Atlanta and is a member of the Technology Association of Georgia. She is a
long-time member of the Marketing Advisory Board for the Center for the Visually
Impaired.
 David R. Stern
David Stern is currently the Sr. Vice President of Scientific Affairs and a
member of the board of directors for CardioMEMS, Inc., an Atlanta based medical
device company that has developed proprietary wireless sensing and communication
technology designed to improve the management of chronic diseases.
David previously served as Vice President and Business Unit Manager of the
Peripheral Technologies Division of C.R. Bard. He holds a B.S. in Biomedical
Engineering from Rensselaer Polytechnic Institute and a M.E. in Biomedical
Engineering from Worcester Polytechnic Institute. David served as SEMDA
president for the 2008/2008 business year.
|
